Dynamic Business Development Executive with a strong background in microbiology and a track record of exceeding sales targets in global pharmaceutical and life science accounts. Specializes in leveraging technology to drive scientific discovery and organizational change. Recognized for expanding business in global accounts like AstraZeneca, abbvie, and Moderna or government accounts like the FDA and NIH.
- AI in Pharma – MIT
- Gene Therapy – Harvard HMX
- Drug Discovery – Harvard HMX
- AI for Business Leaders – Certificate, January 2025
*Scheduled 8 member seminars per year (50-150 attendees): booked venues, all catering details, ran under budget while also increasing membership; and attendance by 200%
*Led a team of 7 to schedule and execute a 3 day seminar attended by 1500 industry scientists, veterinarians, and technicians